Vasopressin Other names: 3-Isoleucyl vasopressin Arginine oxytocin Arginine vasotocin Argipressin Argiprestocin Pitressin tannate

Molecular mass: 2,140.46 g/mol 

Therapeutic indications

Vasopressin is indicated for:

Indication

Population group: only adults (18 years old or older)

at least one of
Diabetes insipidus
Nephrogenic diabetes insipidus

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

Population group: only adults (18 years old or older)

Swollen abdomen

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2018: ARGIPRESSIN Solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈